Other OTC - Delayed Quote • USD
Indiva Limited (NDVAF)
As of 9:36 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 67.59M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Marotta (John A) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Indirect | 10,400 | Nov 1, 2022 |
| Marotta, Carmine Edward Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.13 per share. | Direct | 1,941 | Jul 19, 2022 |
| Welsh (Jennifer Ann) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.13 per share. | Direct | 388 | Jul 19, 2022 |
| Goldman (Rachel Louise) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.13 per share. | Direct | 970 | Jul 19, 2022 |
| Marotta (John A) Director of Issuer | Acquisition or disposition in the public market at price 0.23 per share. | Indirect | 4,600 | Jan 24, 2022 |
| Marotta (John A) Director of Issuer | Exercise of rights at price 0.21 per share. | Direct | 23,444 | Dec 29, 2021 |
| Lafleche (Andre) Director of Issuer | Exercise of rights at price 0.21 per share. | Direct | 23,444 | Dec 29, 2021 |
| Sutherland, Hugh Hamish Director of Issuer | Exercise of rights at price 0.21 per share. | Direct | 23,444 | Dec 29, 2021 |
| Wilson (Russell Liam) Director of Issuer | Conversion or exchange at price 0.21 per share. | Direct | 23,444 | Dec 29, 2021 |
| Yersh, James Director of Issuer | Exercise of rights at price 0.21 per share. | Direct | 23,444 | Dec 29, 2021 |
| Welsh (Jennifer Ann) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 390 | Dec 24, 2021 |
| Lafleche (Andre) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Indirect | 7,817 | Dec 24, 2021 |
| Goldman (Rachel Louise) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 977 | Dec 24, 2021 |
| Marotta, Carmine Edward Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 1,954 | Dec 24, 2021 |
| Goldman (Rachel Louise) Director of Issuer | -- | Direct | -- | Dec 16, 2021 |
| Marotta (John A) Director of Issuer | Acquisition or disposition in the public market at price 0.23 per share. | Indirect | 6,780 | Dec 3, 2021 |
Related Tickers
CANQF CanaQuest Medical Corp.
0.1399
-0.07%
ARYX ARYx Therapeutics, Inc.
0.0000
0.00%
CNGGF Cann Group Limited
0.0275
0.00%
CNADF CanadaBis Capital Inc.
0.0650
0.00%
AOLS Aeolus Pharmaceuticals, Inc.
0.0000
0.00%
SKYI Sky Century Investment, Inc.
0.0035
0.00%
GFI.NZ Greenfern Industries Limited
0.0340
-2.86%
MILFF 1CM Inc.
0.7246
0.00%
XTXXF Adastra Holdings Ltd.
0.1850
0.00%
AYURF Ayurcann Holdings Corp.
0.0204
-11.14%